Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for ...

Study being led by Dr. Jean-Claude Tardif at the Montreal Heart Institute

Related Keywords

Canada ,Montreal ,Quebec ,Canadian ,Jenene Thomas ,Paul David ,Jean Claude Tardif ,Gilles Gagnon ,Ceapro Inc ,Research Center ,Montreal Heart Institute ,Montreal Health Innovations Coordinating Center ,Corporate Communications Advisor ,Montreal Heart ,Region ,